{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:37:48Z","timestamp":1778042268263,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1006\/gyno.1998.5129","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T21:38:48Z","timestamp":1033940328000},"page":"334-338","source":"Crossref","is-referenced-by-count":44,"title":["A Phase II Trial of CPT-11 in Recurrent Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study"],"prefix":"10.1006","volume":"70","author":[{"given":"Katherine Y.","family":"Look","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Levenback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weldon","family":"Chafe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.1998.5129_GO985129RF1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1200\/JCO.1985.3.8.1079","article-title":"Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix\u2014A Gynecologic Oncology Group study","volume":"3","author":"Bonomi","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9378(12)90824-8","article-title":"Phase II trial of ifosfamide and mesna in patients with advanced or recurrent squamous carcinoma of the cervix who had never received chemotherapy: A Gynecology Oncology Group study","volume":"168","author":"Sutton","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF3","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1200\/JCO.1989.7.12.1892","article-title":"A phase II evaluation of mitolactol in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"7","author":"Stehman","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF4","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.1996.14.3.792","article-title":"Paclitaxel has moderate activity in squamous cervix cancer: a Gynecologic Oncology Group study","volume":"14","author":"McGuire","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1997.15.1.165","article-title":"Randomized trial of cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"15","author":"Omura","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF6","first-page":"5077","article-title":"Arrest of replication forks by drug-stabilized topisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin analogues","volume":"49","author":"Hsiang","year":"1989","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1998.5129_GO985129RF7","first-page":"4187","article-title":"Intracellular roles of SN-38, a metabolite of the camptotecin derivative CPT-11 in the antitumor effect of CPT-11","volume":"51","author":"Kawato","year":"1991","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.1998.5129_GO985129RF8","first-page":"224","article-title":"Late phase II study of CPT-11, a topoisomerase I inhibitor, in advanced cervical carcinoma","volume":"11","author":"Takeuchi","year":"1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1200\/JCO.1997.15.2.625","article-title":"Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix","volume":"15","author":"Verschraegen","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF10","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1200\/JCO.1993.11.11.2194","article-title":"Phase I and pharmacokinetic trial of weekly CPT-11","volume":"11","author":"Rothenberg","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF11","series-title":"Chemotherapy of Gynecologic Cancer","article-title":"Design, Analysis and Interpretation of Chemotherapy Trials in Gynecologic Cancer","author":"Blessing","year":"1990"},{"key":"10.1006\/gyno.1998.5129_GO985129RF12","first-page":"1191","article-title":"New anticancer agents in clinical development","volume":"9","author":"Eckhardt","year":"1995","journal-title":"Oncology"},{"key":"10.1006\/gyno.1998.5129_GO985129RF13","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/jnci\/87.24.1876","article-title":"Irinotecan (CPT-11) and characteristic mucosal damages in the mouse ileum and cecum","volume":"87","author":"Ikuno","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.1998.5129_GO985129RF14","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1200\/JCO.1996.14.7.2012","article-title":"Limited-sampling models for irinotecan pharmacokinetics-pharmacodynacis: prediction of biliary index and intestinal toxicity","volume":"14","author":"Mic","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1349-7006.1993.tb02856.x","article-title":"Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts","volume":"84","author":"Kudoh","year":"1993","journal-title":"Jpn J Cancer Res"},{"key":"10.1006\/gyno.1998.5129_GO985129RF16","first-page":"291","article-title":"Irinotecan hydrochloride (CPT-11) combined with cisplatin (CDDP) in patients with relapsed or metastatic ovarian cancer","volume":"15","author":"Sugiyama","year":"1996","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1006\/gyno.1998.5129_GO985129RF17","unstructured":"Ueoka, H, Tabata, M, Shibayama, T, Kiura, K, Harada, M, Segawa, Y, Satoh, T, Hiraki, S, Ohnoshi, T, A phase I study of irinotecan (CPT-11) and cisplatin (CDDP) in advanced lung cancer (ED-SCLC and IIIB\/IV-NSCLC), Proc Am Soc Clin Oncol, 15, 385, 1996, 1154"},{"key":"10.1006\/gyno.1998.5129_GO985129RF18","first-page":"388","article-title":"Phase I study of irinotecan (CPT-11) and cisplatin (CDDP) by divided administration in patients with non-small cell lung cancer (NSCLC)","volume":"15","author":"Kobayashi","year":"1996","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825898951290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825898951290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T01:56:39Z","timestamp":1557280599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825898951290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["S0090825898951290"],"URL":"https:\/\/doi.org\/10.1006\/gyno.1998.5129","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}